Tandem Diabetes Care Inc (TNDM)
42.11
+1.69
(+4.18%)
USD |
NASDAQ |
Jul 08, 16:00
42.11
0.00 (0.00%)
After-Hours: 19:58
Tandem Diabetes Care SG&A Expense (TTM): 352.80M for March 31, 2024
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 352.80M |
December 31, 2023 | 352.50M |
September 30, 2023 | 364.44M |
June 30, 2023 | 369.22M |
March 31, 2023 | 352.22M |
December 31, 2022 | 335.68M |
September 30, 2022 | 309.49M |
June 30, 2022 | 290.31M |
March 31, 2022 | 276.22M |
December 31, 2021 | 261.51M |
September 30, 2021 | 244.53M |
June 30, 2021 | 229.83M |
March 31, 2021 | 213.75M |
December 31, 2020 | 204.90M |
September 30, 2020 | 195.95M |
June 30, 2020 | 190.37M |
March 31, 2020 | 180.49M |
December 31, 2019 | 165.74M |
September 30, 2019 | 152.35M |
June 30, 2019 | 137.21M |
March 31, 2019 | 119.27M |
December 31, 2018 | 105.23M |
Date | Value |
---|---|
September 30, 2018 | 94.35M |
June 30, 2018 | 84.97M |
March 31, 2018 | 84.44M |
December 31, 2017 | 86.38M |
September 30, 2017 | 84.14M |
June 30, 2017 | 84.70M |
March 31, 2017 | 83.68M |
December 31, 2016 | 82.83M |
September 30, 2016 | 84.31M |
June 30, 2016 | 82.75M |
March 31, 2016 | 81.26M |
December 31, 2015 | 78.62M |
September 30, 2015 | 78.19M |
June 30, 2015 | 77.97M |
March 31, 2015 | 76.44M |
December 31, 2014 | 75.12M |
September 30, 2014 | 69.31M |
June 30, 2014 | 62.42M |
March 31, 2014 | 55.68M |
December 31, 2013 | 44.52M |
September 30, 2013 | 36.18M |
June 30, 2013 | 30.64M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (TTM) Range, Past 5 Years
152.35M
Minimum
Sep 2019
369.22M
Maximum
Jun 2023
265.38M
Average
261.51M
Median
Dec 2021
SG&A Expense (TTM) Benchmarks
Insulet Corp | 771.90M |
Abbott Laboratories | 11.15B |
ICU Medical Inc | 611.78M |
Twist Bioscience Corp | 201.91M |
Perspective Therapeutics Inc | 19.11M |